Patents by Inventor Yoshiro KIJIMA

Yoshiro KIJIMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230183241
    Abstract: As a drug substance, a crystal having good physical properties is preferable. However, the crystal form that is most excellent as a drug substance may vary with the compound. In general, it is difficult to predict a crystal form of a drug substance having good physical properties, and it is required to variously examine each compound. Therefore, an object of the present invention is to provide a crystal having good physical properties as a drug substance for a novel compound. The present invention relates to a crystal of the compound represented by the following formula (I) useful for the treatment of an inflammatory bowel disease.
    Type: Application
    Filed: March 10, 2021
    Publication date: June 15, 2023
    Applicant: Kissei Pharmaceutical Co., Ltd.
    Inventors: Yoshiro Kijima, Hideki Takeuchi, Yasushi Takigawa, Yusuke Kawabe
  • Publication number: 20230167108
    Abstract: As a drug substance, a crystal having good physical properties is preferable. However, the crystal form that is most excellent as a drug substance may vary with the compound. In general, it is difficult to predict a crystal form of a drug substance having good physical properties, and it is required to variously examine each compound. Therefore, an object of the present invention is to provide a crystal having good physical properties as a drug substance for a novel compound or a salt thereof. The present invention relates to a crystal of the compound represented by the following formula (I) or a salt thereof useful for the treatment of an inflammatory bowel disease.
    Type: Application
    Filed: March 10, 2021
    Publication date: June 1, 2023
    Applicant: Kissei Pharmaceutical Co., Ltd.
    Inventors: Hideki Takeuchi, Yoshiro Kijima, Akihiro Moriyama
  • Patent number: 10287251
    Abstract: The present invention is to provide a novel pyrazole derivative, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and a pharmaceutical use thereof. The present invention provides a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof, which has TRPM8 inhibitory effects: wherein ring A is C6-10 aryl or the like; X is CR4a or the like; R1 and R2 are a hydrogen atom or the like; R3 is a hydrogen atom or the like; R4 is a hydrogen atom or the like; ring B is C6-10 aryl or the like; R5 is a hydrogen atom or the like; R6a is a hydrogen atom or the like; R7a is a hydrogen atom or the like; R7b is a hydrogen atom or the like; R6b is a hydrogen atom or the like; R8 is a hydrogen atom or the like; n is 0, 1 or 2.
    Type: Grant
    Filed: June 22, 2016
    Date of Patent: May 14, 2019
    Assignee: KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: Hideaki Hirasawa, Fumiya Tanada, Yousuke Mutai, Nobuhiko Fushimi, Junichi Kobayashi, Yoshiro Kijima
  • Publication number: 20180170879
    Abstract: [Problem] The present invention is to provide a novel pyrazole derivative, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and a pharmaceutical use thereof. [Solution] The present invention provides a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof, which has TRPM8 inhibitory effects: wherein ring A is C6-10 aryl or the like; X is CR4a or the like; R1 and R2 are a hydrogen atom or the like; R3 is a hydrogen atom or the like; R4 is a hydrogen atom or the like; ring B is C6-10 aryl or the like; R5 is a hydrogen atom or the like; R6a is a hydrogen atom or the like; R7a is a hydrogen atom or the like; R7b is a hydrogen atom or the like; R6b is a hydrogen atom or the like; R8 is a hydrogen atom or the like; n is 0, 1 or 2.
    Type: Application
    Filed: June 22, 2016
    Publication date: June 21, 2018
    Applicant: KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: Hideaki HIRASAWA, Fumiya TANADA, Yousuke MUTAI, Nobuhiko FUSHIMI, Junichi KOBAYASHI, Yoshiro KIJIMA